Multiple myeloma: 2016 update on diagnosis, risk‐stratification, and management

Multiple myeloma accounts for approximately 10% of hematologic malignancies.The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal failure, anemia, or lytic bone lesio...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of hematology 2016-07, Vol.91 (7), p.719-734
1. Verfasser:	Rajkumar, S. Vincent
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols Bone marrow Hematology Hematopoietic Stem Cell Transplantation Humans Multiple myeloma Multiple Myeloma - diagnosis Multiple Myeloma - therapy Patients Risk Assessment Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!